CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

Phase 2IHL-42XPositive
AI Analysis

Summary

Incannex has commenced participant screening in the DReAMzz Phase 2 study evaluating IHL-42X for obstructive sleep apnea treatment.

Clinical Trial Data

Phase

Phase 2

Importance:4/10
Sentiment:
0.50
clinical_trialphase_2sleep_apneaIHL-42XDReAMzz
Related Companies

Read the original article

Published by yahoo_finance on July 23, 2026 12:00 PM

Read Original